KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Leases (2020 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Leases for 6 consecutive years, with $40.6 million as the latest value for Q4 2025.

  • Quarterly Leases fell 11.25% to $40.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.6 million through Dec 2025, down 11.25% year-over-year, with the annual reading at $40.6 million for FY2025, 11.25% down from the prior year.
  • Leases hit $40.6 million in Q4 2025 for Adaptive Biotechnologies, down from $42.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $92.1 million in Q2 2021 to a low of $40.6 million in Q4 2025.
  • Historically, Leases has averaged $66.8 million across 5 years, with a median of $76.2 million in 2023.
  • Biggest five-year swings in Leases: surged 184.96% in 2021 and later tumbled 38.18% in 2024.
  • Year by year, Leases stood at $87.7 million in 2021, then fell by 7.89% to $80.8 million in 2022, then crashed by 35.5% to $52.1 million in 2023, then decreased by 12.15% to $45.8 million in 2024, then decreased by 11.25% to $40.6 million in 2025.
  • Business Quant data shows Leases for ADPT at $40.6 million in Q4 2025, $42.0 million in Q3 2025, and $43.3 million in Q2 2025.